Idiopathic scrotal calcinosis; a rare scrotal tumour: A Case Report and Review of Literature

Idiopathic scrotal calcinosis is a rare benign disease characterized by multiple, asymptomatic and painless nodules on the scrotum. We herein report this rare disease in a Nigerian adult male and briefly review the relevant literature.Key words: Calcinosis, scrotum, Nigerian adult male, painless nodules

A novel two – factor high order fuzzy time series with applications to temperature and futures exchange forecasting

High order fuzzy time series forecasting methods are more suitable than first order fuzzy time series forecasting methods in dealing with linguistic values. However, existing high order methods lack persuasiveness in dealing objectively with multiple – factor fuzzy time series, recurrent number of fuzzy relationships, and assigning weights to elements of fuzzy forecasting rules. In this paper, a novel two – factor high – order fuzzy time series forecasting method based on fuzzy C-means clustering and particle swarm optimization is proposed to resolve these drawbacks. Fuzzy C-means clustering is utilized in the fuzzification phase to objectively partition the universe of discourse and enable processing of multiple factors. Then, particle swarm optimization is utilized to assign optimal weights to elements of fuzzy forecasting rules. Daily average temperatures of Taipei and Taiwan Futures Exchange (TAIFEX) are used as benchmark data. Average forecasting error performance of 0.85% was obtained for Taipei Temperature forecast. Mean squared error performance of 199.57 was obtained for Taiwan Futures Exchange forecast. The forecasting results showed that the proposed method has higher forecasting performance than other existing methods.Keywords: fuzzy time series, fuzzy c-mean clustering, particle swarm optimization, forecasting, fuzzy relationship

Disseminated Cutaneous Leishmaniasis in HIV positive patient - A Case Report

Disseminated cutaneous leishmaniasis and HIV dual-infection is seldom reported. Leishmaniasis and HIV co-infection may intensify the immunedefect and is the chief reason for atypical presentation and widespread progression of cutaneous leishmaniasis and its defiance to conventional therapy. Here we report a 38-yearold HIV-positive ladywhopresented with a 6-month history of a progressive papule and nodular eruptions of leishmaniasis on face, trunk and extremities that was recalcitrant to treatment.Keywords: Co-infection, Diffuse cutaneous leishmaniasis, HIV infection

RV Sonne Cruise 198-1, 03 May-14 Jun 2008. Singapore - Merak, Indonesia

All plate boundaries are divided into segments - pieces of fault that are distinct from one another, either separated by gaps or with different orientations. The maximum size of an earthquake on a fault system is controlled by the degree to which the propagating rupture can cross the boundaries between such segments. A large earthquake may rupture a whole segment of plate boundary, but a great earthquake usually ruptures more than one segment at once. Earthquakes offshore of Sumatra on December 26th 2004 (MW=9.3) and March 28th 2005 (MW=8.7) ruptured, respectively, 1200-1300 km and 300-400 km of the subduction boundary between the Indian-Australian plate and the Burman and Sumatra blocks. Rupture in the 2004 event started at the southern end of the fault segment, and propagated northwards. The observation that the slip did not propagate significantly southwards in December 2004, even though the magnitude of slip was high at the southern end of the rupture strongly suggests a barrier at that place. Maximum slip in the March 2005 earthquake occurred within ~100 km of the barrier between the 2004 and 2005 ruptures, confirming both the physical importance of the barrier, and the loading of the March 2005 rupture zone by the December 2004 earthquake. Cruise SO198-1, from Singapore to Merak between 3rd May and 14th June 2008 is the first of three cruises, funded by the Natural Environment Research Council (NERC), which will form a coherent set of geophysical observations in the source regions of the 2004 and 2005 great Sumatra earthquakes. Arrays of 50 ocean-bottom seismometers (OBS) were deployed at each of two locations – between the 2004 and 2005 ruptures, and at the southern end of the 2005 rupture - to record shots from a large-capacity airgun array. Approximately 7 days of continuous airgun shooting at 60s interval was completed at each location. 10 OBS were reconfigured for earthquake recording and deployed with a planned retrieval in early 2009. Gravity, Parasound, and swath bathymetry data were recorded continuously while in the permitted area, with magnetic field data recorded throughout the airgun shooting, and 101 XBT casts taken at the OBS deployment locations

Defects induced ferromagnetism in Mn doped ZnO

Single phase Mn doped (2 at %) ZnO samples have been synthesized by solid-state reaction technique. Before the final sintering at 500 C, the mixed powders have been milled for different milling periods (6, 24, 48 and 96 hours). The grain sizes of the samples are very close to each other (~ 32 \pm 4 nm). However, the defective state of the samples is different from each other as manifested from the variation of magnetic properties and electrical resistivity with milling time. All the samples have been found to be ferromagnetic with clear hysteresis loops at room temperature. The maximum value for saturation magnetization (0.11 {\mu}_B / Mn atom) was achieved for 96 hours milled sample. Electrical resistivity has been found to increase with increasing milling time. The most resistive sample bears the largest saturation magnetization. Variation of average positron lifetime with milling time bears a close similarity with that of the saturation magnetization. This indicates the key role played by open volume vacancy defects, presumably zinc vacancies near grain surfaces, in inducing ferromagnetic order in Mn doped ZnO. To attain optimum defect configuration favorable for ferromagnetism in this kind of samples proper choice of milling period and annealing conditions is required.Comment: Accepted in Journal of Magnetism and Magnetic Material

Transmission dynamics and control strategies of COVID-19: a modelling study

In this paper a mathematical model is proposed, which incorporates quarantine and hospitalization to assess the community impact of social distancing and face mask among the susceptible population. The model parameters are estimated and fitted to the model with the use of laboratory confirmed COVID-19 cases in Turkey from March 11 to October 10, 2020. The partial rank correlation coefficient is employed to perform sensitivity analysis of the model, with basic reproduction number and infection attack rate as response functions. Results from the sensitivity analysis reveal that the most essential parameters for effective control of COVID-19 infection are recovery rate from quarantine individuals (δ1), recovery rate from hospitalized individuals (δ4), and transmission rate (β). Some simulation results are obtained with the aid of mesh plots with respect to the basic reproductive number as a function of two different biological parameters randomly chosen from the model. Finally, numerical simulations on the dynamics of the model highlighted that infections from the compartments of each state variables decreases with time which causes an increase in susceptible individuals. This implies that avoiding contact with infected individuals by means of adequate awareness of social distancing and wearing face mask are vital to prevent or reduce the spread of COVID-19 infection

Theoretical analysis of neutron scattering results for quasi-two dimensional ferromagnets

A theoretical study has been carried out to analyse the available results from the inelastic neutron scattering experiment performed on a quasi-two dimensional spin-1/2 ferromagnetic material $K_2CuF_4$. Our formalism is based on a conventional semi-classical like treatment involving a model of an ideal gas of vortices/anti-vortices corresponding to an anisotropic XY Heisenberg ferromagnet on a square lattice. The results for dynamical structure functions for our model corresponding to spin-1/2, show occurrence of negative values in a large range of energy transfer even encompassing the experimental range, when convoluted with a realistic spectral window function. This result indicates failure of the conventional theoretical framework to be applicable to the experimental situation corresponding to low spin systems. A full quantum formalism seems essential for treating such systems.Comment: 16 pages, 6 figures, 1 Table Submitted for publicatio

Whole genome analysis of a schistosomiasis-transmitting freshwater snail

Biomphalaria snails are instrumental in transmission of the human blood fluke Schistosoma mansoni. With the World Health Organization's goal to eliminate schistosomiasis as a global health problem by 2025, there is now renewed emphasis on snail control. Here, we characterize the genome of Biomphalaria glabrata, a lophotrochozoan protostome, and provide timely and important information on snail biology. We describe aspects of phero-perception, stress responses, immune function and regulation of gene expression that support the persistence of B. glabrata in the field and may define this species as a suitable snail host for S. mansoni. We identify several potential targets for developing novel control measures aimed at reducing snail-mediated transmission of schistosomiasis

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

INTRODUCTION Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic. RATIONALE We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs). RESULTS Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants. CONCLUSION Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

BACKGROUND: A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. METHODS: This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. FINDINGS: Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0-75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4-97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8-80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3-4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. INTERPRETATION: ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials. FUNDING: UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D'Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca